CBD Life Sciences Inc.
CBDL · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | -$0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 38% | -23.9% | -61.2% | – |
| Gross Profit | -$0 | $0 | -$0 | $0 |
| % Margin | -78.3% | 39.6% | -71.6% | 40.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -119.1% | -2,948% | -1,820.1% | -124.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -234.9% | -2,948% | -1,941.8% | -172.1% |
| EPS Diluted | 0 | -0 | -0 | -0 |
| % Growth | 100% | 0% | 0% | – |
| Operating Cash Flow | $0 | – | -$0 | – |
| Capital Expenditures | $0 | – | -$0 | – |
| Free Cash Flow | $0 | – | -$0 | – |